免疫系统
生物
转录组
癌症研究
恶性肿瘤
B细胞
细胞生物学
抗体
免疫学
抄写(语言学)
细胞毒性T细胞
核糖核酸
转录因子
T细胞
滤泡树突状细胞
PD-L1
淋巴系统
细胞
FOXP3型
免疫组织化学
CD8型
RNA序列
肿瘤进展
免疫检查点
获得性免疫系统
免疫耐受
生物标志物
作者
Ting Xue,Chuangzhong Deng,Jingya Liu,Ru Yan,Jing Li,Xiheng Hu,Xueying Li,Xiao Xiao,Jietian Jin,Hongzhen Tang,D Chen,Zhengping Zuo,Yujie Liang,Dongbin Wang,Bonan Chen,Hui Han,Zaishang Li
标识
DOI:10.1002/advs.202509742
摘要
Penile squamous cell carcinoma (PSCC) is a malignancy characterized by a poor prognosis and lack of reliable biomarkers, presenting considerable therapeutic challenges. Tertiary lymphoid structures (TLSs) are critical modulators of antitumor immunity; however, the immunological dynamics, particularly the roles of B cells and their interactions with naive T cells in PSCC tissues, remain inadequately understood. This study integrates transcriptomic approaches, including spatial transcriptomics, single-cell sequencing (scRNA-seq), and bulk RNA sequencing (bulk RNA-seq), and immunohistochemistry to elucidate the immune architecture of and functional mechanisms within TLSs. The results reveal a positive correlation between TLS density and patient survival, with CD74⁺ B cells tending to be enriched during early TLS formation. These cells exhibit strong immune activation and a propensity to differentiate into plasma cells. By engaging with naive T cells through HLA-DRA via ligand-receptor interactions, CD74⁺ B cells activate transcription factors, including NFKB1, NFKB2, NFATC1, NFATC2, FOS, and RUNX1, in naive T cells, thereby enhancing the immune response. Consequently, CD74⁺ B cells represent a compelling biomarker for and therapeutic target of PSCC, offering profound insights into the immunological mechanisms that drive PSCC progression and response to immunotherapy.
科研通智能强力驱动
Strongly Powered by AbleSci AI